Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Sarpogrelate

Base Information Edit
  • Chemical Name:Sarpogrelate
  • CAS No.:125926-17-2
  • Deprecated CAS:135309-80-7
  • Molecular Formula:C24H31NO6
  • Molecular Weight:429.51
  • Hs Code.:
  • UNII:19P708E787
  • DSSTox Substance ID:DTXSID7048328
  • Nikkaji Number:J322.421J
  • Wikipedia:Sarpogrelate
  • Wikidata:Q44931
  • NCI Thesaurus Code:C73158
  • Pharos Ligand ID:GWK2QDRWY5RH
  • Metabolomics Workbench ID:153203
  • ChEMBL ID:CHEMBL52939
  • Mol file:125926-17-2.mol
Sarpogrelate

Synonyms:2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl hydrogensuccinate hydrochloride;MCI 9042;MCI-9042;mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate hydrochloride;sarpogrelate

Suppliers and Price of Sarpogrelate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Labseeker
  • Sarpogrelate 99
  • 100g
  • $ 500.00
  • American Custom Chemicals Corporation
  • SARPOGRELATE 95.00%
  • 100G
  • $ 854.70
Total 38 raw suppliers
Chemical Property of Sarpogrelate Edit
Chemical Property:
  • Appearance/Colour:white powder 
  • Vapor Pressure:1.43E-14mmHg at 25°C 
  • Refractive Index:1.551 
  • Boiling Point:585.896 °C at 760 mmHg 
  • PKA:4.25±0.17(Predicted) 
  • Flash Point:308.139 °C 
  • PSA:85.30000 
  • Density:1.165 g/cm3 
  • LogP:3.19740 
  • XLogP3:1.2
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:7
  • Rotatable Bond Count:14
  • Exact Mass:429.21513771
  • Heavy Atom Count:31
  • Complexity:540
Purity/Quality:

98% *data from raw suppliers

Sarpogrelate 99 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Canonical SMILES:CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
  • Recent ClinicalTrials:Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
  • Recent NIPH Clinical Trials:Beneficial Effect of Sarpogrelate on Quality of Life in Patients with Peripheral Arterial Disease
Post RFQ for Price